Results 281 to 290 of about 326,057 (302)

Computational model of cardiomyocyte apoptosis identifies mechanisms of tyrosine kinase inhibitor-induced cardiotoxicity

Journal of Molecular and Cellular Cardiology, 2021
Monika E Grabowska, Jeffrey J Saucerman
exaly  

Tyrosine kinase inhibitors

Reactions Weekly, 2020
openaire   +1 more source

In vitro modulation of cyst formation by a novel tyrosine kinase inhibitor

Kidney International, 1999
William E Sweeney, Ellis D Avner
exaly  

Vatalanib: the clinical development of a tyrosine kinase inhibitor of angiogenesis in solid tumours

Expert Opinion on Investigational Drugs, 2007
Dirk Laurent, Anne L Thomas
exaly  

Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib

Lancet, The, 2007
Maria A Rupnick, Susan M Dallabrida, Jayesh Desai   +2 more
exaly  

ABBV-105, a selective and irreversible inhibitor of Bruton’s tyrosine kinase, is efficacious in multiple preclinical models of inflammation

Modern Rheumatology, 2019
Christian Goess, Christopher M Harris
exaly  

Tyrosine kinase inhibitor resistance in cancer: role of ABC multidrug transporters

Drug Resistance Updates, 2005
Balázs Sarkadi, Csilla Özvegy-Laczka   +1 more
exaly  

Are Tyrosine Kinase Inhibitors the Better Serotonin Inhibitors?

American Journal of Respiratory and Critical Care Medicine, 2013
Djuro, Kosanovic, Ralph, Schermuly
openaire   +2 more sources

Tyrosine Kinase Inhibitors

2008
openaire   +2 more sources

Tyrosine kinase inhibitor sunitinib relieves systemic and oral antigen‐induced anaphylaxes in mice

Allergy: European Journal of Allergy and Clinical Immunology, 2012
K Yamaki
exaly